Brief: Balance Sheet For Liquidation Purposes Shows Enorama Pharma Equity Is Less Than Half Of Registered Share Capital

Enorama Pharma AB

11/03/2026 14:19

March 11 (Reuters) - Enorama Pharma AB ERMA.ST:

THE BALANCE SHEET FOR LIQUIDATION PURPOSES SHOWS THAT THE EQUITY IN ENORAMA PHARMA AB (PUBL) IS LESS THAN HALF OF THE REGISTERED SHARE CAPITAL

BOARD WILL CONVENE A FIRST CONTROL MEETING

REASON FOR NEGATIVE EQUITY IS UNIT ENORAMA PHARMA INC. NOT RECEIVING A REFUSE-TO-FILE DECISION FROM FDA REGARDING ITS APPLICATIONS FOR PRIOR APPROVAL OF TOBACCO PRODUCTS

Source text: ID:nWkr2nlJ45

Further company coverage: ERMA.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))